Published in Am J Clin Nutr on April 01, 1995
Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer (2008) 1.12
Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer (2009) 1.00
The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J (2008) 0.99
The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle (2011) 0.94
Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer (2010) 0.92
The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open (2014) 0.87
Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C. Virol J (2010) 0.83
Rapid measurement of total body water to facilitate clinical decision making in hospitalized elderly patients. J Gerontol A Biol Sci Med Sci (2009) 0.83
Bioelectrical impedance analysis to estimate body composition in surgical and oncological patients: a systematic review. Eur J Clin Nutr (2014) 0.81
Comparison of two nutritional assessment methods in gastroenterology patients. World J Gastroenterol (2010) 0.80
Bioelectrical impedance phase angle and subjective global assessment in detecting malnutrition among newly diagnosed head and neck cancer patients. Eur Arch Otorhinolaryngol (2015) 0.77
Body composition analysis in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.75
Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer. Curr Oncol (2016) 0.75
Bioimpedance vector pattern in Taiwanese and Polish college students detected by bioelectric impedance vector analysis: preliminary observations. ScientificWorldJournal (2012) 0.75
Capacitance of Membrane As a Prognostic Indicator of Survival in Head and Neck Cancer. PLoS One (2016) 0.75
Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool. Front Physiol (2017) 0.75
Investigating the clinical significance of body composition changes in patients undergoing chemoradiation for oropharyngeal cancer using analytic morphomics. Springerplus (2016) 0.75
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev (2003) 4.03
Undereating and underrecording of habitual food intake in obese men: selective underreporting of fat intake. Am J Clin Nutr (2000) 3.99
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax (2009) 3.12
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Validation of bioelectrical-impedance measurements as a method to estimate body-water compartments. Am J Clin Nutr (1994) 2.94
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol (1997) 2.09
Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med (1999) 2.03
Underreporting of habitual food intake is explained by undereating in highly motivated lean women. J Nutr (1999) 1.98
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med (2001) 1.96
Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr (2009) 1.96
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax (1996) 1.94
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax (2001) 1.94
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J (1996) 1.91
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J (2001) 1.88
Assessment of energy expenditure for physical activity using a triaxial accelerometer. Med Sci Sports Exerc (1994) 1.88
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
Daily physical activity assessment with accelerometers: new insights and validation studies. Obes Rev (2013) 1.80
Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax (1991) 1.79
Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.73
Improving assessment of daily energy expenditure by identifying types of physical activity with a single accelerometer. J Appl Physiol (1985) (2009) 1.70
Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J (1999) 1.62
Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther (1990) 1.61
Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest (1997) 1.60
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr (2000) 1.58
Changes in fat oxidation in response to a high-fat diet. Am J Clin Nutr (1997) 1.56
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol (1995) 1.56
Effect of exercise training on total daily physical activity in elderly humans. Eur J Appl Physiol Occup Physiol (1999) 1.55
Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem (2001) 1.55
Doubly labelled water validation of three physical activity questionnaires. Int J Sports Med (1999) 1.54
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53
Postoperative pulmonary function abnormalities after coronary artery bypass surgery. Respir Med (1992) 1.53
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group. Eur J Cancer (1997) 1.52
Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1998) 1.51
Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) (1999) 1.49
Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (1998) 1.47
Use of a triaxial accelerometer to validate reported food intakes. Am J Clin Nutr (2001) 1.46
Measurement of the components of nonexercise activity thermogenesis. Am J Physiol Endocrinol Metab (2001) 1.45
Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas (2010) 1.42
Evaluation of quality of life in sarcoidosis patients. Respir Med (1998) 1.40
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.38
Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2000) 1.38
Seasonal changes in metabolic and temperature responses to cold air in humans. Physiol Behav (2004) 1.33
A dual-respiration chamber system with automated calibration. J Appl Physiol (1985) (1997) 1.32
Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J (1994) 1.30
Methods to assess physical activity with special reference to motion sensors and accelerometers. IEEE Trans Biomed Eng (1991) 1.27
Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J (1997) 1.26
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med (1995) 1.25
The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr (2000) 1.25
Assessment of the physical activity level with two questions: validation with doubly labeled water. Int J Obes (Lond) (2008) 1.25
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol (2000) 1.22
Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord (2001) 1.22
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.21
Validation of the Tracmor triaxial accelerometer system for walking. Med Sci Sports Exerc (2001) 1.20
Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol (2000) 1.20
Satiety related to 24 h diet-induced thermogenesis during high protein/carbohydrate vs high fat diets measured in a respiration chamber. Eur J Clin Nutr (1999) 1.20
Advances in physical activity monitoring and lifestyle interventions in obesity: a review. Int J Obes (Lond) (2011) 1.19
Appetite at "high altitude" [Operation Everest III (Comex-'97)]: a simulated ascent of Mount Everest. J Appl Physiol (1985) (1999) 1.18
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Daily physical activity of schoolchildren with spastic diplegia and of healthy control subjects. J Pediatr (1995) 1.15
Physical inactivity as a determinant of the physical activity level in the elderly. Int J Obes Relat Metab Disord (2001) 1.14
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol (2000) 1.14
Adverse effects of the indoor environment on respiratory health in primary school children. Environ Res (1995) 1.14
Energy, substrate and protein metabolism in morbid obesity before, during and after massive weight loss. Int J Obes Relat Metab Disord (2000) 1.13
Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (1991) 1.13
Daily physical activity assessment: comparison between movement registration and doubly labeled water. J Appl Physiol (1985) (1996) 1.11
Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils. Am J Respir Cell Mol Biol (2001) 1.10
Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med (1998) 1.09
Tracmor system for measuring walking energy expenditure. Eur J Clin Nutr (2003) 1.08
Use of the doubly labeled water technique in humans during heavy sustained exercise. J Appl Physiol (1985) (1986) 1.08
Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 1.06
Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr (1999) 1.06
Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.04
Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr (1998) 1.04
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J (2007) 1.03